igf-1 lr3 and leutinizing hormone in Aesthetic Anti-Aging Medicine: Benefits and Risks Frontiers | Growth Hormone/Insulin Growth

Breast Cancer In hormone-dependent breast cancer cells, the IGF-1R and ER are frequently co-expressed

William Seeds uses the following protocols depending on which variation of CJC-1295 is being administered: CJC-1295 WITHOUT DAC: A saturation dose of 100 mcg is typically used (1 mg/kg), as any higher dosage adds minimally to the pulse of GH released CJC-1295 WITH DAC: Twice a week at 100 mcg, OR 100 mcg daily (this dose works best for short-term treatment to elevate IGF1 above physiologic levels) He also recommends avoiding food consumption 30 minutes before GHRH use and 1.5 hours after using it (due to carbs and fats blunting GH release), and therefore its best to take it either before bed (thus improving sleep) or in the morning before your first meal

Biochemical and biophysical research communications , 280 (1), 132138

Not Combining With GHRP or Ipamorelin CJC1295 works best when paired with a GHRP such as Ipamorelin, which stimulates the ghrelin receptor and enhances pituitary GH release